The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 Mar 2010 07:00

RNS Number : 6904I
Standard Life Euro Pri Eqty Tst PLC
17 March 2010
 



 

 

Standard Life European Private Equity Trust PLC

 

Investment update for the quarter from 1 October 2009 to 31 December 2009

 

·; NAV increased by 6.5% to 175.6p for the quarter ended 31 December 2009

·; The increase in NAV during the quarter was driven by £24.2 million (8.5% of NAV) of unrealised gains on the portfolio on a constant exchange rate basis; this was offset by unrealised foreign exchange losses of £6.9 million

·; 100% by value of the portfolio was valued by the respective underlying managers at 31 December 2009

·; For the six months ended 31 December 2009 NAV increased by 16.2%

·; Outstanding commitments down to £194.7 million at 31 December 2009, from a peak of £425.9 million at 31 December 2008

·; Net indebtedness of £37.8 million at 31 December 2009

 

For the quarter ended 31 December 2009 the Company's net asset value per ordinary share ("NAV") rose 6.5% to 175.6p at 31 December 2009, from 164.9p at 30 September 2009. The principal reason for the uplift in NAV was the rise in comparable listed valuation multiples in the second half of 2009, which was reflected in the 31 December 2009 valuations undertaken by the underlying managers of the Company's fund interests. At 31 December 2009 the Company's net assets were £282.8 million (30 September 2009 - £265.6 million).

 

The closing value of the Company's portfolio of private equity fund interests was £320.8 million at 31 December 2009 (30 September 2009 - £293.1 million). Total net unrealised gains for the quarter were £17.3 million, of which £24.2 million were net unrealised gains on a constant exchange rate basis and £6.9 million were net unrealised foreign exchange losses. During the quarter ended 31 December 2009 sterling appreciated by 2.9% against the euro and 1.0% against the dollar.

 

Reflecting the quiet European private equity market, a total of £1.7 million was received by way of distributions from the Company's private equity fund interests in the quarter, of which net realised gains and income were £0.1 million. As for new investment activity, during the quarter the Company's portfolio of private equity fund interests drew down a total of £12.0 million.

 

At 31 December 2009 the Company had aggregate outstanding commitments to its private equity fund interests of £194.7 million (30 September 2009 - £227.8 million). No new fund commitments were made in the period. A significant proportion of the fall in outstanding commitments during the quarter arose from the sale by the Company of €18.6 million of its €31.5 million of existing outstanding commitments to Apax Europe VII. This transaction was reported in detail in the Company's first interim management statement released on 27 January 2010.

 

At 31 December 2009 the Company had net indebtedness of £37.8 million (30 September 2009 - net indebtedness of £27.3 million). The Company has a £100 million revolving credit term facility.

 

Since 31 December 2009 there appears to be have been a slight pick up in transaction activity in the European private equity market, most noticeably in terms of realisations. In the period from 1 January 2010 to 15 March 2010 the Company has received £4.9 million of distributions and funded £2.3 million of draw downs.

 

Taking account of draw downs, distributions, expenses and other movements since 1 January 2010, the Company's total outstanding commitments and net indebtedness were £193.9 million and £35.1 million respectively as at 15 March 2010.

 

It is anticipated that the Company will release its interim announcement for the six months ending 31 March 2010 on or around 28 May 2010.

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under section 842 of the Income and Corporation Taxes Act 1988. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQQLFFBXFEBBD
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.